Compound dossier · evidence, sources, and live market
Sermorelin
Growth-hormone secretagogue Limited evidence 3 cited studies 62 live vendors
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth-hormone-releasing hormone (GHRH), the fragment characterized in research as the active core of the parent molecule. In laboratory research it is classified as a growth-hormone secretagogue and studied as a GHRH analog that acts on pituitary GHRH receptors in laboratory models. This page tracks research-use-only (RUO) vendor pricing for Sermorelin so researchers can compare cost per milligram across suppliers; it is not intended for human or veterinary use.
Evidence brief
Sermorelin is a growth-hormone-releasing hormone (GHRH) analogue (the first 29 amino acids of GHRH) historically studied as a diagnostic agent and as a treatment in growth-hormone-deficient children.
first-party prices captured 37m ago
Compare by exact vialThe small sealed glass container a compound ships in. size: 5mg (29 vendors)10mg (41 vendors)
Formerly FDA-approved (Geref); withdrawn from the US market in 2009 for commercial reasons, not safety. No FDA-approved product today — prescribed only as a compounded drug.Research use only — not medical advice.
These figures are what pepmg still publishes about price: the floor, the middle, the spread and how many sources we track, computed from listings we captured first-party and refreshed on the same schedule as always. We no longer publish the individual listings or the sellers behind them.
Computed from 75 in-stock listings across 62 sources we captured first-party, with bulk vials, blends and statistical outliers excluded so the figures compare like with like. The spread is the highest tracked price divided by the lowest — how much the same milligram varies depending on where you look. The chart is the daily minimum; days we did not capture are left out rather than filled in.
- What the research says about sermorelin Limited evidence
Sermorelin is a growth-hormone-releasing hormone (GHRH) analogue (the first 29 amino acids of GHRH) historically studied as a diagnostic agent and as a treatment in growth-hormone-deficient children.
Read the full review →
- Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? PubMed ↗
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency PubMed ↗
Sermorelin, a 29 amino acid analogue of human growth hormone-releasing hormone (GHRH), is the shortest synthetic peptide with full biological activity of GHRH. Intravenous and subcutaneous sermorelin specifically stimulate growth hormone…
- Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males PubMed ↗
Male hypogonadism is an increasingly prevalent clinical condition that affects patients' quality of life and overall health. Obesity and metabolic syndrome can both cause and result from hypogonadism. Although testosterone remains the gold…
A few representative studies, each summarized on this site with the PubMed record linked beside it — not an endorsement or a claim that any result applies to human use. Read them and judge for yourself. Everything here is research use only.
▸ Why compare $/mg for Sermorelin?
Per-milligram prices for Sermorelin vary widely because vials are sold in different peptide masses (commonly 2 mg, 5 mg, or 10 mg), and larger vials usually lower the effective $/mg, while listed weight may reflect net peptide or gross salt/acetate content. Synthesis scale, stated HPLC purity, lyophilization quality, and shipping or cold-chain handling also differ between vendors, so normalizing to $/mg is the only reliable way to compare like with like.
▸ Reading the COA
For Sermorelin, a certificate of analysis should confirm identity by mass spectrometry against the expected monoisotopic mass for the 29-residue GHRH(1-29) sequence (molecular formula around C149H246N44O42S, roughly 3358 Da), and report HPLC purity, with many research suppliers listing 98%+ as a common threshold. Check that the reported net peptide content matches the labeled vial mass, since acetate salt and residual water can inflate gross weight. Watch for truncated or deletion sequences and deamidation byproducts in the HPLC trace, which are typical impurities for peptides of this length. A COA is about verifying the identity and purity of the material, not about any outcome.
▸ FAQ
▸ Same cluster
| CJC-1295 | $2.84/mg | vs Sermorelin → |
| Ipamorelin | $2.60/mg | vs Sermorelin → |
| NAD+ | $0.05/mg | vs Sermorelin → |
| Tesamorelin | $3.70/mg | vs Sermorelin → |
| MOTS-c | $1.40/mg | vs Sermorelin → |
| Epithalon | $1.10/mg | vs Sermorelin → |
| SS-31 | $1.42/mg | vs Sermorelin → |
| Humanin | $8.90/mg | vs Sermorelin → |
| FOXO4-DRI | $6.26/mg | vs Sermorelin → |
| GHRP-2 | $2.13/mg | vs Sermorelin → |
| GHRP-6 | $2.10/mg | vs Sermorelin → |
| Hexarelin | $4.90/mg | vs Sermorelin → |
| MK-677 | $2.68/mg | vs Sermorelin → |
| MK-777 | $3.45/mg | vs Sermorelin → |